ESR1 and breast cancer: Using these engineered models, we observed in vitro and in vivo that expression of either ERmut(Y537S) or ERmut(D538G), even in the presence of background wt ERα expression, produced ligand-independent and tamoxifen-resistant breast cancer growth (Figure 3, Supplement Figure S4).